Cutaneous Lupus Erythematosus: Clinico-Pathologic Correlation

March 2018 in “ Italian Journal of Dermatology and Venereology ”

Raffaele Filotico, Valentina Mastrandrea

cutaneous lupus erythematosus CLE autoimmune disease acute CLE subacute CLE chronic CLE lupus tumidus systemic lupus erythematosus SLE interface dermatitis lymphocytic infiltrate hyperkeratosis PAS-positive material deposits photoprotection topical steroids calcineurin inhibitors systemic hydroxychloroquine skin lupus lupus topical corticosteroids Protopic Elidel Plaquenil

Studysummary This article reviews clinical and histopathological aspects of cutaneous lupus erythematosus and its treatment, emphasizing the importance of photoprotection and outlining current therapies, but reports no new experimental results.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on minervamedica.it →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community cb-03-01 research chem (winlevi/clascoterone cream)

in Technology 3 upvotes 2 years ago

The user is considering using CB or clascoterone for hair loss, potentially as an alternative to RU. They're also contemplating asking a dermatologist for topical clascoterone cream to apply to their temple.

community Women complaining of bad effects from Winlevi (Clascoterone 1%)

11 upvotes 9 months ago

Women experienced severe reactions, including Topical Steroid Withdrawal (TSW), from using Winlevi (Clascoterone 1%) on their faces. Concerns were raised about the potential risks of higher concentrations, especially for hair loss treatment.

community EMA is re-examining Winlevi (clascoterone at lower concentration)

8 upvotes 1 year ago

Clascoterone in Winlevi, a topical AR antagonist, is being re-examined due to concerns about HPA axis suppression in adolescents, but it's unlikely to be banned for adult use in androgenetic alopecia (AGA). The European Medicines Agency recommended refusing Winlevi for acne vulgaris, but this may not affect Breezula's approval for AGA.

community Hives/Rash from Kx 826 Pyrilutamide???

1 upvotes 1 year ago

OP developed hives after using Kx 826 (Pyrilutamide) 1% twice daily for 3 weeks. The hives appeared on the arms, chest, and groin area.

community CTE and lots of shedding for over a year

in Female 4 upvotes 2 years ago

A female user has experienced severe hair shedding since stopping birth control in late 2022, diagnosed as telogen effluvium with no signs of androgenetic alopecia. Despite healthy living and optimal bloodwork, she continues to shed hair daily but also sees significant regrowth.

community Winlevi Clascoterone- resultssss

4 upvotes 5 days ago

The conversation is about using Winlevi Clascoterone cream for hair loss. The user is considering adding it to their routine, which includes a topical hair growth serum, and is seeking feedback on its effectiveness.

Related Research

2 / 2 results

research Lupus Erythematosus: Systemic and Cutaneous Manifestations

144 citations , September 2006 in “Clinics in Dermatology”

This article outlines manifestations of systemic lupus erythematosus, noting rapid joint symptom improvement with corticosteroids and antimalarial drug responsiveness for skin symptoms, and links anti-Ro with photosensitive rash and subacute lupus.

research Clinical Manifestations of Cutaneous Lupus Erythematosus

148 citations , February 2005 in “Autoimmunity Reviews”

This article discusses the distinct skin findings associated with lupus erythematosus, noting that some are specific to lupus while others are nonspecific and occur with various diseases; it reports no new results.